|
|
- Congratulations to our 2024 CPhA award winners!
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: 161 - 162 Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Volume 157, Issue 4, Page 161-162, July/August 2024.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-07-26T10:55:19Z DOI: 10.1177/17151635241260931 Issue No: Vol. 157, No. 4 (2024)
- Pharmacists’ prescribing of opioids in Nova Scotia under Health
Canada’s Controlled Drugs and Substances Act temporary exemption during the COVID-19 pandemic-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Ronald Watema-Lord, Ingrid Sketris, Heather Neville, Mark Asbridge, Chiranjeev Sanyal Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-08-15T04:22:54Z DOI: 10.1177/17151635241267008
- Role of the pharmacist caring for people at risk of or living with HIV in
Canada-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Stacey Tkachuk, Erin Ready, Shanna Chan, Jennifer Hawkes, Tracy Janzen Cheney, Jeff Kapler, Denise Kreutzwiser, Linda Akagi, Michael Coombs, Pierre Giguere, Christine Hughes, Deborah Kelly, Sheri Livingston, Dominic Martel, Mark Naccarato, Salin Nhean, Carley Pozniak, Tasha Ramsey, Linda Robinson, Jonathan Smith, Jaris Swidrovich, Jodi Symes, Deborah Yoong, Alice Tseng Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-08-03T05:04:51Z DOI: 10.1177/17151635241267350
- CPhA Strategic Plan 2024–2026
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-08-03T05:00:28Z DOI: 10.1177/17151635241269087
- Thanks, Renée
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Ross T. Tsuyuki, Rosemary Killeen Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-08-03T04:57:52Z DOI: 10.1177/17151635241269081
- A future-forward influenza immunization model of care for high-risk
patients in pharmacies: A Canadian consensus-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Aaron Sihota, Cameron Bonell, Brittany Buffone, Sherilyn K.D. Houle, Michael Kani, Josh Kim, Erica MacLean, Anas Nseir, Pavithra Ravinatarajan, Francis Richard, Tiana Tilli, Carolyn Whiskin, Victor Wong, Paul Roumeliotis Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-07-30T08:04:12Z DOI: 10.1177/17151635241263548
- Community pharmacists’ comfort levels with and barriers to application
of an expanded scope of practice in Québec-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Léonie Rouleau, Léa Prince-Duthel, Marie-Claude Vanier, Nicolas Dugré, Anne Maheu, Line Guénette Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print. Background:In recent years, community pharmacists have seen their profession transition from a dispensing-focused role to a rapidly evolving clinically oriented practice. In Québec, Bill 31, adopted in 2020, increased the clinical opportunities for pharmacists with independent prescribing privileges in various defined clinical situations. As this expanded role can lead to different barriers, it is crucial to explore pharmacists’ comfort levels with implementing such changes in their practice.Methods:A web-based survey was conducted from March 25 to May 28, 2021, among community pharmacists in Québec. We collected data with a questionnaire developed for this study. Questions were grouped into 4 domains: (1) characteristics of the respondents; (2) workload and work setting; (3) comfort level with, and barriers to, adjusting medications and following up pharmacologic treatments (86 clinical situations evaluated); and (4) general barriers and facilitators to implementation.Results:A total of 146 community pharmacists completed the questionnaire. Most were women (71.9%), younger than 50 years of age (86.2%), had a bachelor’s degree (64.4%) as their highest academic level and had more than 10 years of experience as pharmacists (56.8%). Most of them worked exclusively in a community pharmacy (86.3%). Among the 86 clinical situations evaluated, there were 16 in which at least 80% of respondents felt comfortable. The main barriers identified were a lack of knowledge, experience and dedicated time and difficulties integrating these activities into the workflow; facilitators were having an adequate environment and resources.Conclusion:This study shows community pharmacists can confidently adjust pharmacotherapy for several conditions. However, they must have adequate time and resources. Also, the more complex the clinical situations were, the less comfortable community pharmacists felt adjusting pharmacotherapy. This study identified several areas where continuing education, training and mentoring could be offered and where the work environment and organization could be improved. Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-07-30T08:03:12Z DOI: 10.1177/17151635241264517
- Does the type of pharmacy used influence medication adherence' A
retrospective observational study in Aotearoa, New Zealand-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: James Nind, Carlo A. Marra, Shane Scahill, Charlotte Siermans, Alesha Smith Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print. Background:Community pharmacies in New Zealand have varying ownership and operational structures. Unlike independent pharmacies, corporate and hybrid pharmacies do not charge prescription copayments.Objectives:This research aims to determine whether people receiving free prescriptions from corporate and hybrid pharmacies have greater medication adherence than the users of independent pharmacies.Methods:A nationwide, retrospective, observational study linked 1 year of dispensing data (1/05/2022 to 30/04/2023) from the Pharmaceutical Collection to patient enrollment data using a National Health Index number to identify demographics of different pharmacy-type users. People were assigned to a particular type of pharmacy if they collected at least 70% of their prescriptions from there; if they did not meet this threshold, they were defined as mixed users. People were classified as adherent if dispensing data showed they collected their supply of medication to cover at least 80% of the study period.Results:The sample captured 218,080 people taking at least 1 diabetes medication, with a total of 360,079 unique medications being included in the analysis. The majority, 156,893, used independent pharmacies. The type of pharmacy used was shown to be a significant predictor of adherence. Corporate and hybrid pharmacy users were 1.11 (95% CI 1.07–1.14) and 1.07 (95% CI 1.04–1.11) times as likely to not be adherent than the users of independent pharmacies. Mail order pharmacy users were the most likely to be adherent, whereas mixed pharmacy users were the least likely to be adherent.Conclusions:These findings suggest that prescription copayments are not the most significant barrier to medication adherence. Further research may identify more efficient ways of improving medication adherence than removing prescription copayments for all. Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-07-29T05:34:20Z DOI: 10.1177/17151635241267025
- Accessibility reality check
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Kaitlyn E. Watson, Ross T. Tsuyuki, Dave L. Dixon, Shania Liu, Yazid N. Al Hamarneh Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-06-10T08:47:45Z DOI: 10.1177/17151635241256621
- Make your mark! Become a CPS author or reviewer
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-06-05T05:37:19Z DOI: 10.1177/17151635241260932
- A pharmacist-led heart failure stewardship initiative for
guideline-directed medical therapy in hospitalized patients with reduced ejection fraction-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Gemma-Dawn A. MacDonald, Rochelle M. Johnston, Andrew J. Flewelling Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print. Background:Heart failure with reduced ejection fraction (HFrEF) is a progressive disease with high rates of hospitalization and mortality. The Canadian Cardiovascular Society recommends treating patients with HFrEF with medications from 4 standard medication classes—this is known as guideline-directed medical therapy (GDMT). However, despite clear evidence and recommendations, GDMT agents are known to be underutilized in the HFrEF population.Objective:To determine if the implementation of a prescriber-alert stewardship tool for hospitalized patients with HFrEF will increase the frequency of GDMT prescribing with all classes during hospitalization.Methods:Utilization of GDMT in patients with HFrEF between admission and discharge pre- and post-implementation of a prescriber alert stewardship tool was compared. Patients admitted to a cardiology stepdown unit between January and April 2022 had a stewardship-alert tool placed on their chart for physician review, while those admitted during the same time frame 1 year prior did not.Results:Following the use of a prescriber alert, there was a statistically significant increase in prescribing for β-blockers (38.1% to 95.2%; p < 0.001), mineralocorticoid receptor antagonists (9.5% to 66.7%; p < 0.001) and combination GDMT (9.5% to 52.4%; p = 0.004) from admission to discharge. A statistically significant increase in the prescribing of β-blockers (47.6% to 76.2%; p = 0.004) and angiotensin-converting enzyme inhibitors (21.4% to 40.5%; p = 0.008) was still observed without the use of the prescriber alert.Conclusion:A pharmacist-led heart failure stewardship tool initiative increased uptake of GDMT in patients with HFrEF. Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-06-01T06:06:47Z DOI: 10.1177/17151635241249952
- Enhancing hypertension detection and control through a hypertension
certification program for pharmacists: A cluster randomized trial (The RxPATH Study)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Kaitlyn E. Watson, Jonathan C.H. Chan, Bo Pan, Yazid N. Al Hamarneh, Ross T. Tsuyuki Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print. Importance:We designed an online educational program for primary care health care providers, the Hypertension Canada Professional Certification Program (HC-PCP), based upon its 2020 guidelines.Objective:The objective was to determine the effect of the HC-PCP, taken by pharmacists, on systolic blood pressure (BP) in patients with poorly controlled hypertension.Design:Stepped wedge cluster randomized trial (unit of randomization was the pharmacy).Participants:Patients with poorly controlled hypertension (BP>140/90 mmHg or>130/80 mmHg [diabetes]) in community pharmacies in Alberta, Canada, were recruited by their pharmacist.Intervention:Pharmacists completed the HC-PCP program, then provided care to their patients with poorly controlled hypertension according to what they learned in the course.Control:Pharmacists were given a copy of the Hypertension Canada guidelines and provided their usual care to their patients prior to undertaking the HC-PCP later.Main outcome and measure:The primary outcome was a difference in change in systolic BP at 3 months between groups, while the secondary outcome was patient satisfaction with using the Consultation Satisfaction Questionnaire.Results:We enrolled 890 patients from 59 pharmacies (including 104 pharmacists). Using a linear mixed-effect model with BP reduction as the dependent variable and independent variables of treatment allocation, baseline BP, site effect and patient effect, the intervention was associated with a 4.76 mmHg (95% confidence interval, 2.02–7.50, p < 0.0001) systolic BP reduction at 3 months. Patient satisfaction with using the Consultation Satisfaction Questionnaire was high at 75.9 (/90).Conclusion and relevance:Most educational programs are not evaluated at the patient care level. The HC-PCP taken by pharmacists resulted in a 4.76 mmHg systolic BP reduction in their patients over 3 months. This would have major implications for public health, reducing heart disease, stroke and kidney failure. Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-05-31T11:23:32Z DOI: 10.1177/17151635241254089
- Review of the top nephrology studies of 2020-2023
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Jo-Anne Wilson, Jennifer Pitman, Judith Marin, Lori D. Wazny, Marisa Battistella Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-05-21T07:11:11Z DOI: 10.1177/17151635241250028
- Harmonizing leadership: Blending transactional and transformational styles
in pharmacy practice-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Liam Jackman Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-05-20T12:43:57Z DOI: 10.1177/17151635241253593
- How to change workflow to enhance implementation of professional services
in community pharmacies: A deprescribing case study-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Kelda Newport, Aili V. Langford, Aisling M. McEvoy, Deborah V. Kelly, Tara Smith, Cara Tannenbaum, Justin P. Turner Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2024-05-06T08:25:14Z DOI: 10.1177/17151635241246975
- Corrigendum to Extended antithrombotic therapy for secondary prevention of
cardiovascular events: A tool for pharmacists-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2022-04-19T12:45:34Z DOI: 10.1177/17151635221098004
|